Three-day educational forum welcomes world-renowned specialists to
discuss latest treatment advances
TORONTO, April 22 /CNW/ - The CLL Patient Advocacy Group, Juravinski
Cancer Centre and The Leukemia & Lymphoma Society of Canada are pleased to
host "Trends in Treating CLL," a three-day educational forum for healthcare
professionals, CLL patients and their families and friends.
A number of speakers, including world-renowned CLL specialists, will
offer the entire community involved in the diagnosis, treatment and support of
patients the latest information and treatment advances for this incurable and
devastating disease. Discussion topics include disease biology, current
diagnostic and prognostic testing and state of the art therapies.
This conference is a follow up to the initial conference held in 2007,
developed on behalf of all people living with CLL to advance diagnosis and
treatment and improve quality and possible extension of life.
Media are invited to attend this year's conference to learn first-hand
about the recent explosion of new therapeutic drug research worldwide and
sophisticated prognostic tools that have significantly improved the treatment
of CLL patients.
What: "Trends in Treating CLL" - a three-day international
conference for healthcare professionals, CLL patients, their
families and friends
Who: Chaired by Dr. Ronan Foley, Juravinski Cancer Centre and
will feature presentations by international thought leaders,
including Drs. William G. Wierda, Neil Kay, Joseph Flynn and
Ryan Robetorye (designer of Hemescan).
Where: Sheraton Fallsview Hotel and Conference Centre, Niagara
When: Friday, April 24 - Sunday, April 26, 2009.
Interviews: Elizabeth Locatelli Turgeon, CLL Patient Advocacy Group
(CLLPAG), Board Chair
Dr. Ronan Foley, Associate Professor, Department of
Pathology and Molecular Medicine, McMaster University and
CLL Conference Chair
Dr. Neil Kay, Professor of Medicine, Mayo Clinic and Chronic
Lymphocytic Leukemia Research Consortium (CRC)
Background: In chronic lymphocytic leukemia (CLL), too many mature white
blood cells are produced. When the onset of the cancer is
gradual, and the disease progresses slowly, it is called
chronic leukemia. In 2005, 1829 new cases of CLL were
diagnosed in Canada. People in their 60s are most commonly
affected by CLL(1).
For further information:
For further information: For a detailed conference agenda, attendance
information or to arrange an interview, please contact: Jennifer Dolan,
Edelman, (416) 979-1120 ext. 257, email@example.com